Condition: Fibrillation, Atrial · Atrial Cardiomyopathy · Sponsor: University Medical Center Groningen
The goal of clinical trial is to compare AF ablation to pharmacological rhythm management (being rate or rhythm control) in AF patients with signs of atrial cardiomyopathy (as defined by left atrial volume index \>34 ml/m2) The main objective it aims to answer is to determine whether AF ablation compared to pharmacological rhythm management in ACMP patients with AF reduces the incidence of the composite primary endpoint of CV death and first CV hospitalization/urgent visit.
This description comes directly from the study's public registry record.
Michiel Rienstra, Prof. dr. · +31503616161 · m.rienstra@umcg.nl
Nick L van Vreeswijk, Drs. · 0624678451 · nickvanvreeswijk@gmail.com
Always discuss trial participation with your own doctor first.
| UMCG | Groningen, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06200311